NCT04405115 Improving Survivorship Care for Older Adults After Chemotherapy
| NCT ID | NCT04405115 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Survivorship |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2021-02-16 |
| Primary Completion | 2028-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2021-02-16 with a primary completion date of 2028-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The researchers want to find out if older adults receiving a survivorship care plan followed by a geriatric assessment visit improves quality of life and satisfaction with care compared to receiving only a survivorship care plan for older adults who have completed chemotherapy for cancer treatment.
Eligibility Criteria
Inclusion Criteria: 1. age 65 years and above and 2. Have diagnosis of cancer and have completed chemotherapy with curative (not palliative) intent and 3. have been scheduled to receive a survivorship care plan from an oncology navigator. Exclusion Criteria: 1. advanced dementia or serious cognitive impairment that would impede ability to participate in the interview 2. nursing home resident.
Contact & Investigator
Haifaa Abdulhaq, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT04405115 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Survivorship. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04405115 currently recruiting?
Yes, NCT04405115 is actively recruiting participants. Contact the research team at JMosholder@communitymedical.org for enrollment information.
Where is the NCT04405115 trial being conducted?
This trial is being conducted at Clovis, United States.
Who is sponsoring the NCT04405115 clinical trial?
NCT04405115 is sponsored by University of California, San Francisco. The principal investigator is Haifaa Abdulhaq, MD at University of California, San Francisco. The trial plans to enroll 70 participants.